GASTROINTESTINAL NEUROENDOCRINE CARCINOMA

GASTROINTESTINAL NEUROENDOCRINE CARCINOMA was reported 29 times

GASTROINTESTINAL NEUROENDOCRINE CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LURBINECTEDIN 1 0.0009
1 CALCIFEDIOL 1 0.0004
2 LUTETIUM LU 177 DOTATATE 2 0.0003
3 DAROLUTAMIDE 1 0.0002
4 REPAGLINIDE 1 0.0001
5 EVEROLIMUS TABLETS 2 0.0001
6 OCTREOTIDE ACETATE 3 0.0001
7 PEGFILGRASTIM 1 0.0001
8 PANCRELIPASE 2 0.0001
9 OLAPARIB 1 0.0000
10 VEDOLIZUMAB 4 0.0000
11 EVEROLIMUS 2 0.0000
12 MESALAMINE 1 0.0000
13 MYCOPHENOLATE MOFETIL 4 0.0000
14 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 4 0.0000
15 METHYLPREDNISOLONE 4 0.0000
16 ETOPOSIDE 2 0.0000
17 ATEZOLIZUMAB 1 0.0000
18 UPADACITINIB 2 0.0000
19 PREDNISOLONE ORAL SOLUTION 4 0.0000
20 LIRAGLUTIDE 1 0.0000
21 BEVACIZUMAB 2 0.0000
22 CARBOPLATIN 2 0.0000
23 CALCIUM CARBONATE 1 0.0000
24 APIXABAN 1 0.0000
25 DOCETAXEL ANHYDROUS 1 0.0000
26 DOCETAXEL 1 0.0000
27 CISPLATIN 1 0.0000
28 DULAGLUTIDE 1 0.0000
29 TIRZEPATIDE 2 0.0000
30 RAMIPRIL 1 0.0000
31 INSULIN LISPRO 1 0.0000
32 OMEPRAZOLE MAGNESIUM 3 0.0000
33 AMLODIPINE BESYLATE 1 0.0000
34 NATALIZUMAB 1 0.0000
35 INTERFERON BETA-1A 1 0.0000
36 ATORVASTATIN CALCIUM 1 0.0000
37 INSULIN GLARGINE 1 0.0000
38 FOLIC ACID 1 0.0000
39 AMLODIPINE 1 0.0000
40 METOPROLOL TARTRATE 1 0.0000
41 METFORMIN ER 500 MG 1 0.0000
42 LENALIDOMIDE 1 0.0000
43 ACETAMINOPHEN 1 0.0000
44 PREDNISONE 1 0.0000
45 ASPIRIN 1 0.0000
46 ADALIMUMAB 1 0.0000